VALIDATION IMAGES
Lane 1: Jurkat cell lysates probed with Calreticulin Monoclonal Antibody, Unconjugated (bsm-51748M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: HepG2 cell lysates; Lane 2: Jurkat cell lysates; Lane 3: Hela cell lysates; Lane 4: MCF-7 cell lysates; Lane 5: SH-SY5Y cell lysates; Lane 6: K562 cell lysates; Lane 7: NIH/3T3 cell lysates; Lane 8: C6 cell lysates; Lane 9: CHO cell lysates probed with Calreticulin Monoclonal Antibody, Unconjugated (bsm-51748M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Human SH-SY5Y cell lysates; Lane 2: Human HeLa cell lysates; Lane 3: Human K562 cell lysates; Lane 4: Human HL-60 cell lysates; Lane 5: Human A431 cell lysates; Lane 6: Human Jurkat cell lysates; Lane 7: Human HepG2 cell lysates; Lane 8: Human MCF-7 cell lysates probed with Calreticulin Monoclonal Antibody, Unconjugated (bsm-51748M) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Mouse NIH/3T3 cell lysates; Lane 2: Mouse Testis tissue lysates; Lane 3: Rat Testis tissue lysates probed with Calreticulin Monoclonal Antibody, Unconjugated (bsm-51748M) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.